Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MOR.DE Stock Summary
Top 10 Correlated ETFs
MOR.DE
In the News
MOR.DE Financial details
Company Rating
Strong Buy
Market Cap
2.56B
Income
-189.19M
Revenue
238.36M
Book val./share
1.3
Cash/share
18.16
Dividend
-
Dividend %
-
Employees
524
Optionable
No
Shortable
Yes
Earnings
29 Apr 2024
P/E
12.49
Forward P/E
-
PEG
4.45
P/S
5.07
P/B
36.28
P/C
3.73
P/FCF
-6.69
Quick Ratio
3.14
Current Ratio
3.57
Debt / Equity
12.97
LT Debt / Equity
12.68
-
-
EPS (TTM)
-5.66
EPS next Y
-
EPS next Q
-
EPS this Y
25.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
11.15%
Revenue last 5Y
27.13%
Revenue Q/Q
-7.4%
EPS Q/Q
-136.57%
-
-
-
-
SMA20
1.52%
SMA50
48.89%
SMA100
204.55%
Inst Own
0.32%
Inst Trans
0.83%
ROA
4%
ROE
96%
ROC
-0.11%
Gross Margin
77%
Oper. Margin
-81%
Profit Margin
35%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
14.52-68.0
52W High
-0.44%
52W Low
+383.57%
RSI
72
Rel Volume
0.26
Avg Volume
474.92K
Volume
122.12K
Perf Week
1.27%
Perf Month
3.36%
Perf Quarter
147.99%
Perf Half Y
168.76%
-
-
-
-
Beta
0.603
-
-
Volatility
0.3%, 0.78%
Prev Close
0.15%
Price
67.7
Change
-0.22%
MOR.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.27 | 10.08 | 5.38 | 8.15 | 6.94 | |
Net income per share | -3.26 | 3.01 | -15.4 | -4.42 | -5.53 | |
Operating cash flow per share | -2.54 | 1.08 | -14.41 | -10.74 | -8.62 | |
Free cash flow per share | -2.65 | -0.43 | -15.2 | -11.18 | -8.71 | |
Cash per share | 8.62 | 33.52 | 29.75 | 26.56 | 19.9 | |
Book value per share | 12.49 | 19.1 | 7.33 | 4.61 | 1.43 | |
Tangible book value per share | 11.07 | 16.92 | -27.81 | -31.78 | -33.15 | |
Share holders equity per share | 12.49 | 19.1 | 7.33 | 4.61 | 1.43 | |
Interest debt per share | 1.42 | 12.74 | 15.19 | 13.35 | 21.74 | |
Market cap | 4.01B | 3.05B | 1.11B | 451.54M | 1.17B | |
Enterprise value | 4.01B | 3.26B | 1.31B | 388.65M | 1.65B | |
P/E ratio | -38.97 | 31.17 | -2.16 | -2.99 | -6.18 | |
Price to sales ratio | 55.95 | 9.31 | 6.19 | 1.62 | 4.92 | |
POCF ratio | -50.1 | 86.5 | -2.31 | -1.23 | -3.96 | |
PFCF ratio | -47.9 | -216.89 | -2.19 | -1.18 | -3.93 | |
P/B Ratio | 10.17 | 4.91 | 4.54 | 2.87 | 23.91 | |
PTB ratio | 10.17 | 4.91 | 4.54 | 2.87 | 23.91 | |
EV to sales | 55.92 | 9.95 | 7.32 | 1.4 | 6.93 | |
Enterprise value over EBITDA | -40.59 | 25.52 | -7.34 | 2.25 | -16.88 | |
EV to operating cash flow | -50.07 | 92.41 | -2.73 | -1.06 | -5.58 | |
EV to free cash flow | -47.88 | -231.7 | -2.59 | -1.02 | -5.52 | |
Earnings yield | -0.03 | 0.03 | -0.46 | -0.33 | -0.16 | |
Free cash flow yield | -0.02 | 0 | -0.46 | -0.85 | -0.25 | |
Debt to equity | 0.11 | 0.51 | 1.33 | 2.16 | 12.97 | |
Debt to assets | 0.09 | 0.19 | 0.13 | 0.14 | 0.31 | |
Net debt to EBITDA | 0.02 | 1.63 | -1.13 | -0.36 | -4.88 | |
Current ratio | 4.93 | 6.02 | 3.98 | 3.91 | 3.08 | |
Interest coverage | -46.26 | 1.24 | -1.53 | 1.39 | -2.3 | |
Income quality | 0.78 | 0.36 | 0.94 | 2.43 | 1.56 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.51 | 0.16 | 0.44 | 0.3 | 0.36 | |
Research and developement to revenue | 1.51 | 0.43 | 1.25 | 1.07 | 1.19 | |
Intangibles to total assets | 0.09 | 0.04 | 0.46 | 0.52 | 0.59 | |
Capex to operating cash flow | 0.05 | -1.4 | 0.05 | 0.04 | 0.01 | |
Capex to revenue | -0.05 | -0.15 | -0.15 | -0.05 | -0.01 | |
Capex to depreciation | -0.59 | -5.92 | -2.59 | -1.45 | -0.27 | |
Stock based compensation to revenue | 0.09 | 0.03 | 0.01 | 0.01 | 0.11 | |
Graham number | 30.26 | 35.97 | 50.41 | 21.41 | 13.34 | |
ROIC | -0.21 | 0.53 | -0.39 | -2.58 | -0.36 | |
Return on tangible assets | -0.23 | 0.06 | -0.37 | -0.13 | -0.23 | |
Graham Net | 5.89 | 3.83 | -37.21 | -36.19 | -35.89 | |
Working capital | 242.13M | 1.01B | 848.43M | 810.69M | 549.71M | |
Tangible asset value | 349.9M | 550.33M | -929.02M | -1.09B | -1.14B | |
Net current asset value | 201.96M | 168.63M | -1.18B | -1.15B | -1.16B | |
Invested capital | 0.11 | 0.51 | 1.33 | 2.16 | 12.97 | |
Average receivables | 19.19M | 55.09M | 87.81M | 99.07M | 77.5M | |
Average payables | 8.94M | 29.11M | 60.67M | 56.18M | 33.48M | |
Average inventory | 266.69K | 5.13M | 15.36M | 22.5M | 43.16M | |
Days sales outstanding | 103.47 | 100.06 | 174.35 | 147.37 | 65.34 | |
Days payables outstanding | 321.8 | 1.89K | 836.41 | 289.62 | 177.56 | |
Days of inventory on hand | 8.7 | 396.37 | 235.27 | 182.07 | 388.22 | |
Receivables turnover | 3.53 | 3.65 | 2.09 | 2.48 | 5.59 | |
Payables turnover | 1.13 | 0.19 | 0.44 | 1.26 | 2.06 | |
Inventory turnover | 41.93 | 0.92 | 1.55 | 2 | 0.94 | |
ROE | -0.26 | 0.16 | -2.1 | -0.96 | -3.87 | |
Capex per share | -0.12 | -1.52 | -0.78 | -0.45 | -0.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.39 | 1.82 | 1.56 | 1.87 | 1.57 | |
Net income per share | 9.64 | -1.28 | -2.16 | -3.5 | 1.28 | |
Operating cash flow per share | -3.08 | -2.08 | -3.69 | -0.99 | -1.5 | |
Free cash flow per share | -3.25 | -2.1 | -3.69 | -1.03 | -1.52 | |
Cash per share | 26.55 | 23.17 | 19.66 | 18.76 | 18.16 | |
Book value per share | 4.61 | 2.84 | 0.93 | -1.96 | 1.3 | |
Tangible book value per share | -31.77 | -32.85 | -34.78 | -12.41 | -30.25 | |
Share holders equity per share | 4.61 | 2.84 | 0.93 | -1.96 | 1.3 | |
Interest debt per share | 1.19 | 9.05 | 9.06 | 9.19 | 17.14 | |
Market cap | 451.67M | 504.29M | 935.48M | 886.39M | 1.29B | |
Enterprise value | 388.78M | 493.62M | 1.03B | 981.07M | 1.76B | |
P/E ratio | 0.34 | -2.87 | -3.16 | -1.85 | 6.66 | |
Price to sales ratio | 5.53 | 8.09 | 17.6 | 13.89 | 21.75 | |
POCF ratio | -4.29 | -7.08 | -7.43 | -26.32 | -22.81 | |
PFCF ratio | -4.07 | -7.04 | -7.42 | -25.09 | -22.53 | |
P/B Ratio | 2.87 | 5.2 | 29.54 | -13.24 | 26.2 | |
PTB ratio | 2.87 | 5.2 | 29.54 | -13.24 | 26.2 | |
EV to sales | 4.76 | 7.92 | 19.42 | 15.38 | 29.84 | |
Enterprise value over EBITDA | 1.68 | -35.38 | -25.24 | -19.47 | 65.46 | |
EV to operating cash flow | -3.69 | -6.93 | -8.19 | -29.13 | -31.28 | |
EV to free cash flow | -3.5 | -6.89 | -8.19 | -27.77 | -30.9 | |
Earnings yield | 0.73 | -0.09 | -0.08 | -0.13 | 0.04 | |
Free cash flow yield | -0.25 | -0.14 | -0.13 | -0.04 | -0.04 | |
Debt to equity | 2.16 | 2.9 | 8.88 | -3.69 | 12.97 | |
Debt to assets | 0.14 | 0.13 | 0.13 | 0.12 | 0.31 | |
Net debt to EBITDA | -0.27 | 0.76 | -2.37 | -1.88 | 17.73 | |
Current ratio | 3.91 | 3.6 | 3.57 | 3.14 | 3.08 | |
Interest coverage | 0.14 | -2.46 | -1.78 | -0.76 | -9.4 | |
Income quality | -0.32 | 1.6 | 1.7 | 0.28 | -1.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.51 | 0.17 | 0.32 | 0.24 | 0.73 | |
Research and developement to revenue | 1.15 | 1.33 | 1.07 | 0.99 | 1.36 | |
Intangibles to total assets | 0.52 | 0.55 | 0.57 | 0.17 | 0.59 | |
Capex to operating cash flow | 0.05 | 0.01 | 0 | 0.05 | 0.01 | |
Capex to revenue | -0.07 | -0.01 | 0 | -0.03 | -0.01 | |
Capex to depreciation | -2.2 | -0.15 | -0.03 | -0.61 | -0.34 | |
Stock based compensation to revenue | 0.04 | 0.03 | 0.2 | 0 | -0.03 | |
Graham number | 31.62 | 9.06 | 6.72 | 12.42 | 6.14 | |
ROIC | -0.05 | -0.16 | -0.2 | -0.24 | -0.12 | |
Return on tangible assets | 0.29 | -0.04 | -0.08 | -0.07 | 0.06 | |
Graham Net | -36.18 | -37.02 | -39.18 | -42.37 | -32.75 | |
Working capital | 810.69M | 685.68M | 621.17M | 543.76M | 549.71M | |
Tangible asset value | -1.09B | -1.12B | -1.19B | -424M | -1.14B | |
Net current asset value | -1.15B | -1.18B | -1.25B | -1.37B | -1.16B | |
Invested capital | 2.16 | 2.9 | 8.88 | -3.69 | 12.97 | |
Average receivables | 110.23M | 95.21M | 82.12M | 72.27M | 50.5M | |
Average payables | 117.6M | 93.9M | 134.52M | 118.39M | 72.67M | |
Average inventory | 26.69M | 29.76M | 53.5M | 71.13M | 66.3M | |
Days sales outstanding | 123.82 | 112.73 | 145.9 | 82.32 | 64.98 | |
Days payables outstanding | 225.17 | 639.98 | 1.4K | 697.12 | 175.54 | |
Days of inventory on hand | 141.55 | 151.29 | 838.24 | 420.39 | 383.79 | |
Receivables turnover | 0.73 | 0.8 | 0.62 | 1.09 | 1.39 | |
Payables turnover | 0.4 | 0.14 | 0.06 | 0.13 | 0.51 | |
Inventory turnover | 0.64 | 0.59 | 0.11 | 0.21 | 0.23 | |
ROE | 2.09 | -0.45 | -2.34 | 1.79 | 0.98 | |
Capex per share | -0.17 | -0.01 | 0 | -0.05 | -0.02 |
MOR.DE Frequently Asked Questions
What is MorphoSys AG stock symbol ?
MorphoSys AG is a DE stock and trading under the symbol MOR.DE
What is MorphoSys AG stock quote today ?
MorphoSys AG stock price is $67.7 today.
Is MorphoSys AG stock public?
Yes, MorphoSys AG is a publicly traded company.